IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Remus Pharmaceuticals Limited is an Pharmaceutical based company, located in Ahmedabad, Remus Pharmaceuticals Limited IPO size was 47.69 Cr. and was issued at 1229.00 per share. The share of Remus Pharmaceuticals Limited were listed at 1711.00 per share and are currently trading at 667.70 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Providing engineering, procurement, construction (EPC) and turnkey solutions for Wastewater Treatment Projects (WWT)
Surat
Business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants
New Delhi
Remus Pharmaceuticals operates in Pharmaceutical and Marketing And Distribution Pharmaceutical Drugs. The Issue is listed on NSE EMERGE in May, 2023. Remus Pharmaceuticals IPO size was 47.69 Cr. with Issue price of 1229.00 .
Merchant Banker(s) of Remus Pharmaceuticals IPO: Beeline Capital Advisors Private Limited
Remus Pharmaceuticals IPO subscription was 57.21 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Remus Pharmaceuticals IPO listed at a listing price of 1711.00 against the offer price of 1229.00.
The current market price of Remus Pharmaceuticals is 667.70.
Why Us?
